Halesha D. Basavarajappa

Author

Indiana University – Purdue University Indianapolis ORCID

Also Known As

HALESHA D. BASAVARAJAPPA, Halesha Basavarajappa, Halesha D Basavarajappa, Halesha D. Basavarajappa, Halesha Dhurvigere Basavarajappa

Publications

540

Citations

H-Index

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Gachon University Cairo University Indiana University Health

About

Halesha D. Basavarajappa is an author at Indiana University – Purdue University Indianapolis specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	281
2	Natural Sciences	5	5	263
3	Biochemistry	5	5	246
4	Health Sciences	1	1	19
5	Biomolecular Engineering	1	1	19

Halesha D. Basavarajappa

Publications

443

Citations

H-Index

Page 1

	Year	Citations
Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating <i>Mycobacterium tuberculosis</i> Pravin S. Shirude, Prashanti Madhavapeddi, Julie A. Tucker, ACS Chemical Biology Crystal StructureTuberculosis PreventionPharmacotherapyAntimicrobial ChemotherapyPharmaceutical Chemistry	2012	86
Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B Manoj Kale, Anandkumar Raichurkar, Shahul Hameed P, Journal of Medicinal Chemistry Antiparasitic AgentMolecular BiologyAntimicrobial ChemotherapyPharmaceutical ChemistryMtb Mic	2013	66
Ferrochelatase is a therapeutic target for ocular neovascularization Halesha D. Basavarajappa, Rania S. Sulaiman, Xiaoping Qi, EMBO Molecular Medicine	2017	59
The first synthesis of the antiangiogenic homoisoflavanone, cremastranone Bit Lee, Halesha D. Basavarajappa, Rania S. Sulaiman, Organic & Biomolecular Chemistry	2014	58
Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy Ramesh R. Kale, Manoj Kale, David Waterson, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAntitubercular ActivityBiochemistryMedicineNatural Sciences	2013	41
Transcriptional and Epigenetic Regulation of KIF14 Overexpression in Ovarian Cancer Brigitte L. Thériault, Halesha D. Basavarajappa, Harvey Lim, PLoS ONE Cancer Cells Kif14Cancer BiologyEpigeneticsTumor BiologyOvarian Cancer	2014	36
Synthesis and Mechanistic Studies of a Novel Homoisoflavanone Inhibitor of Endothelial Cell Growth Halesha D. Basavarajappa, Bit Lee, Xiang Fei, PLoS ONE Molecular PharmacologyDiabetic RetinopathyNovel Homoisoflavanone InhibitorAngiogenesisDerivatives	2014	34
The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae (<i>sensu</i> APGII) Sianne Schwikkard, Hannah Whitmore, Kamakshi Sishtla, Journal of Natural Products	2019	26
Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids Bit Lee, Wei Sun, Hyungjun Lee, Bioorganic & Medicinal Chemistry Letters OptogeneticsPhotoaffinity ProbesBiochemistryPhotochemistryAntiangiogenic Homoisoflavonoids	2016	19
<i>KIF14</i> As An Oncogene In Retinoblastoma: A Target For Novel Therapeutics? Halesha D. Basavarajappa, Timothy W. Corson Future Medicinal Chemistry Tumor BiologyNovel TherapeuticsOncogenic AgentMedicinePathology	2012	18

Page 1